Detalhe da pesquisa
1.
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.
Am J Hematol
; 98(5): 770-783, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36814396
2.
Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients.
Int J Mol Sci
; 21(8)2020 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32344757
3.
Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease.
Am J Hematol
; 92(9): 885-891, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28543356
4.
Intensive consolidation with G-CSF support: Tolerability, safety, reduced hospitalization, and efficacy in acute myeloid leukemia patients ≥60 years.
Am J Hematol
; 92(10): E567-E574, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28699225
5.
Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations.
Support Care Cancer
; 25(11): 3295-3304, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28842778
6.
In vitro and in vivo effects of JAK2 inhibition in chronic myelomonocytic leukemia.
Eur J Haematol
; 97(6): 562-567, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27157043
7.
Clofarabine/cyclophosphamide for debulking before stem cell transplantation.
Eur J Clin Invest
; 44(8): 775-83, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24942362
8.
Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
Ann Hematol
; 93(11): 1825-38, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24951123
9.
Updated Austrian treatment algorithm for metastatic triple-negative breast cancer.
Wien Klin Wochenschr
; 2023 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37682349
10.
Updated Austrian treatment algorithm in HER2+ metastatic breast cancer.
Wien Klin Wochenschr
; 134(1-2): 63-72, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35089396
11.
Identification of CD203c as a New Basophil-Specific Flow-Marker in Ph+ Chronic Myeloid Leukemia.
Cells
; 12(1)2022 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36611797
12.
Is ruxolitinib a potentially useful drug in hematological malignancies with RAS pathway hyperactivation?
Haematologica
; 101(12): e492, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27903714
13.
Austrian recommendations for the management of essential thrombocythemia.
Wien Klin Wochenschr
; 133(1-2): 52-61, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33215234
14.
Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study.
Eur J Cancer
; 143: 101-112, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33296830
15.
A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting : R-EFECT study.
Wien Klin Wochenschr
; 132(15-16): 415-422, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32533444
16.
The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study.
Ther Adv Med Oncol
; 12: 1758835919900872, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32313566
17.
Correction to: Ruxolitinib therapy formyelofibrosis in Austria : Consensus on therapy management.
Wien Klin Wochenschr
; 131(1-2): 47, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30542777
18.
The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data source for further biomedical research.
Wien Klin Wochenschr
; 131(17-18): 410-418, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31321531
19.
Diagnosis, management and response criteria of iron overload in myelodysplastic syndromes (MDS): updated recommendations of the Austrian MDS platform.
Expert Rev Hematol
; 11(2): 109-116, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29292655
20.
Austrian recommendations for the management of polycythemia vera.
Wien Klin Wochenschr
; 130(17-18): 535-542, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30027395